ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Kanoria Chemicals reported strong FY26 performance with 30% consolidated revenue growth and 90% EBITDA growth. Management highlights operational efficiencies and a strategic 'Vision 2030' roadmap.
Kanoria Chemicals & Industries Limited conducted its 66th Annual General Meeting on September 2, 2026, via video conferencing. The meeting covered routine ordinary and special business resolutions.
Kanoria Chemicals & Industries Ltd reported revenue from operations of ₹460.4 Cr (+128.6% YoY) and net profit of ₹26.4 Cr for Q1 FY27.
Kanoria Chemicals & Industries Limited has issued a notice for its 66th Annual General Meeting scheduled for September 2, 2026, to conduct routine shareholder business.
Kanoria Chemicals provided shareholders, who have not registered their email, with a web-link to access the Annual Report for FY 2025-26 as per regulation 36(1)(b).
Kanoria Chemicals & Industries Limited has scheduled its 66th Annual General Meeting for September 2, 2026. The meeting will be held virtually to conduct ordinary and special business.
Kanoria Chemicals & Industries Limited will hold its 66th Annual General Meeting on September 2, 2026. The company has dispatched the Annual Report for the fiscal year 2025-26.
Kanoria Chemicals & Industries Limited has scheduled a board meeting on August 11, 2026. The board will consider and approve unaudited financial results for the June quarter.
Kanoria Chemicals & Industries Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The report identifies minor administrative deviations but confirms broad regulatory compliance.
Kanoria Chemicals approved FY26 audited results and recommended no dividend. The board also re-appointed Smt. Suhana Murshed as an Independent Director for five years.
Kanoria Chemicals & Industries Ltd reported revenue from operations of ₹304.4 Cr (+42.3% YoY) and net profit of ₹31.6 Cr for Q4 FY26.
Kanoria Chemicals & Industries approved audited FY26 financial results, reporting standalone total income of ₹90,223 Lakhs. The board recommended no dividend for the financial year.
Kanoria Chemicals scheduled a board meeting on May 25, 2026. The board will review annual financial results and consider a potential dividend recommendation.
Kanoria Chemicals announced its RTA, CB Management Services, merged with MUFG Intime India effective May 8, 2026. Services to shareholders will continue seamlessly under the new name.
Kanoria Chemicals clarified that recent stock price movements are purely market-driven. The company confirmed all price-sensitive information has been duly disclosed to exchanges.
Kanoria Chemicals & Industries Limited allotted 4,95,000 unlisted 7% Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares to R. V. Investment and Dealers Limited. The transaction aggregates to ₹49.50 Crore. This disclosure was made pursuant to SEBI Insider Trading Regulations.
Kanoria Chemicals & Industries Limited approved the preferential allotment of 4,95,000 NCRPS to promoter group entity R. V. Investment and Dealers Limited. The allotment, valued at ₹49.50 Crore, involves shares with a face value of ₹1,000 each. This capital raise strengthens the company's financial structure through promoter-led funding.
Kanoria Chemicals & Industries Limited's Board met on April 13, 2026, to approve the Letter of Offer (PAS-4) for Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS). This follows prior shareholder approval at the EGM held on April 1, 2026. The meeting concluded at 11:20 a.m.